Psychedelic and MDMA-Related Adverse Effects-A Call for Action.
Otto Simonsson, Matthew W. Johnson, Peter S. Hendricks
JAMA Health Forum November 1, 2024 DOI: 10.1001/jamahealthforum.2024.3630 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Viewpoint Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy MDMA |
| Keywords | Adverse effects Patient safety Preparation & integration |
| Citations | 10 |
| Key points | Better understanding of risks associated with psychedelic and MDMA use is needed, and four key research goals are identified to ensure safe and ethical practice. |
Abstract
This Viewpoint discusses the need to better understand potential risks associated with psychedelic and 3,4-methylenedioxymethamphetamine (MDMA) use to ensure safe and ethical practice and identifies 4 key research goals.
Citations in the library
Cited by 10
- Longitudinal associations of naturalistic psychedelic use with psychotic and manic symptoms. Psychological Medicine March 31, 2025
- Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review. Neuroscience & Biobehavioral Reviews June 1, 2025
- The science of psychedelic medicine. Nature Medicine February 6, 2026
- Gaps in US Psychedelic Policy and How to Close Them JAMA Health Forum November 7, 2025
- Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences. International Journal of Drug Policy December 13, 2025
and 5 more in the library
Cites 9
- Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review Journal of Psychopharmacology August 26, 2022
- Psychedelic Drug Legislative Reform and Legalization in the US JAMA Psychiatry December 7, 2022
- Extended difficulties following the use of psychedelic drugs: A mixed methods study PLoS One October 24, 2023
- Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis. Psychiatry Research May 1, 2024
- Acute Adverse Effects of Therapeutic Doses of Psilocybin JAMA Network Open April 10, 2024
and 4 more in the library